Global Infant Formula Testing 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01250013

Publication Date:

February 7, 2024

Pages:

107

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Infant Formula Testing market size was valued at US$ 846.2 million in 2023. With growing demand in downstream market, the Infant Formula Testing is forecast to a readjusted size of US$ 1354.4 million by 2030 with a CAGR of 7.0% during review period.
The research report highlights the growth potential of the global Infant Formula Testing market. Infant Formula Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Infant Formula Testing. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Infant Formula Testing market.
Infant formula are amongst the most heavily regulated and tested food products in the world and come with rigorously checked nutritional labelling to ensure they are what they say they are.
According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children's consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children's Industry shows that in 80% of families in China, children's expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is 楼17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is 楼485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.
Key Features:
The report on Infant Formula Testing market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Infant Formula Testing market. It may include historical data, market segmentation by Type (e.g., NMR Spectroscopy, Chromatography), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Infant Formula Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Infant Formula Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Infant Formula Testing industry. This include advancements in Infant Formula Testing technology, Infant Formula Testing new entrants, Infant Formula Testing new investment, and other innovations that are shaping the future of Infant Formula Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Infant Formula Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Infant Formula Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Infant Formula Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Infant Formula Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Infant Formula Testing market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Infant Formula Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Infant Formula Testing market.
麻豆原创 Segmentation:
Infant Formula Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
NMR Spectroscopy
Chromatography
Mass Spectrometry
Polymerase Chain Reaction
Immunoassay
Others
Segmentation by application
Allergens Testing
Adulteration testing
Nutritional Analysis
Microbiology Testing
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent Technologies, Inc.
Covance Inc.
Thermo Fisher Scientific Inc.
Silliker Inc.
Accugen Laboratories, Inc.
Intertek Group PLC
Eurofins Central Analytical Laboratories
ELISA Technologies, Inc.
Bureau Veritas S.A.
SGS SA

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Infant Formula Testing 麻豆原创 Size 2019-2030
2.1.2 Infant Formula Testing 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Infant Formula Testing Segment by Type
2.2.1 NMR Spectroscopy
2.2.2 Chromatography
2.2.3 Mass Spectrometry
2.2.4 Polymerase Chain Reaction
2.2.5 Immunoassay
2.2.6 Others
2.3 Infant Formula Testing 麻豆原创 Size by Type
2.3.1 Infant Formula Testing 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Infant Formula Testing 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Infant Formula Testing Segment by Application
2.4.1 Allergens Testing
2.4.2 Adulteration testing
2.4.3 Nutritional Analysis
2.4.4 Microbiology Testing
2.4.5 Others
2.5 Infant Formula Testing 麻豆原创 Size by Application
2.5.1 Infant Formula Testing 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Infant Formula Testing 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Infant Formula Testing 麻豆原创 Size by Player
3.1 Infant Formula Testing 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Infant Formula Testing Revenue by Players (2019-2024)
3.1.2 Global Infant Formula Testing Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Infant Formula Testing Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Infant Formula Testing by Regions
4.1 Infant Formula Testing 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Infant Formula Testing 麻豆原创 Size Growth (2019-2024)
4.3 APAC Infant Formula Testing 麻豆原创 Size Growth (2019-2024)
4.4 Europe Infant Formula Testing 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Infant Formula Testing 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Infant Formula Testing 麻豆原创 Size by Country (2019-2024)
5.2 Americas Infant Formula Testing 麻豆原创 Size by Type (2019-2024)
5.3 Americas Infant Formula Testing 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infant Formula Testing 麻豆原创 Size by Region (2019-2024)
6.2 APAC Infant Formula Testing 麻豆原创 Size by Type (2019-2024)
6.3 APAC Infant Formula Testing 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Infant Formula Testing by Country (2019-2024)
7.2 Europe Infant Formula Testing 麻豆原创 Size by Type (2019-2024)
7.3 Europe Infant Formula Testing 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infant Formula Testing by Region (2019-2024)
8.2 Middle East & Africa Infant Formula Testing 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Infant Formula Testing 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Infant Formula Testing 麻豆原创 Forecast
10.1 Global Infant Formula Testing Forecast by Regions (2025-2030)
10.1.1 Global Infant Formula Testing Forecast by Regions (2025-2030)
10.1.2 Americas Infant Formula Testing Forecast
10.1.3 APAC Infant Formula Testing Forecast
10.1.4 Europe Infant Formula Testing Forecast
10.1.5 Middle East & Africa Infant Formula Testing Forecast
10.2 Americas Infant Formula Testing Forecast by Country (2025-2030)
10.2.1 United States Infant Formula Testing 麻豆原创 Forecast
10.2.2 Canada Infant Formula Testing 麻豆原创 Forecast
10.2.3 Mexico Infant Formula Testing 麻豆原创 Forecast
10.2.4 Brazil Infant Formula Testing 麻豆原创 Forecast
10.3 APAC Infant Formula Testing Forecast by Region (2025-2030)
10.3.1 China Infant Formula Testing 麻豆原创 Forecast
10.3.2 Japan Infant Formula Testing 麻豆原创 Forecast
10.3.3 Korea Infant Formula Testing 麻豆原创 Forecast
10.3.4 Southeast Asia Infant Formula Testing 麻豆原创 Forecast
10.3.5 India Infant Formula Testing 麻豆原创 Forecast
10.3.6 Australia Infant Formula Testing 麻豆原创 Forecast
10.4 Europe Infant Formula Testing Forecast by Country (2025-2030)
10.4.1 Germany Infant Formula Testing 麻豆原创 Forecast
10.4.2 France Infant Formula Testing 麻豆原创 Forecast
10.4.3 UK Infant Formula Testing 麻豆原创 Forecast
10.4.4 Italy Infant Formula Testing 麻豆原创 Forecast
10.4.5 Russia Infant Formula Testing 麻豆原创 Forecast
10.5 Middle East & Africa Infant Formula Testing Forecast by Region (2025-2030)
10.5.1 Egypt Infant Formula Testing 麻豆原创 Forecast
10.5.2 South Africa Infant Formula Testing 麻豆原创 Forecast
10.5.3 Israel Infant Formula Testing 麻豆原创 Forecast
10.5.4 Turkey Infant Formula Testing 麻豆原创 Forecast
10.5.5 GCC Countries Infant Formula Testing 麻豆原创 Forecast
10.6 Global Infant Formula Testing Forecast by Type (2025-2030)
10.7 Global Infant Formula Testing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Information
11.1.2 Agilent Technologies, Inc. Infant Formula Testing Product Offered
11.1.3 Agilent Technologies, Inc. Infant Formula Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Agilent Technologies, Inc. Main Business Overview
11.1.5 Agilent Technologies, Inc. Latest Developments
11.2 Covance Inc.
11.2.1 Covance Inc. Company Information
11.2.2 Covance Inc. Infant Formula Testing Product Offered
11.2.3 Covance Inc. Infant Formula Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Covance Inc. Main Business Overview
11.2.5 Covance Inc. Latest Developments
11.3 Thermo Fisher Scientific Inc.
11.3.1 Thermo Fisher Scientific Inc. Company Information
11.3.2 Thermo Fisher Scientific Inc. Infant Formula Testing Product Offered
11.3.3 Thermo Fisher Scientific Inc. Infant Formula Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Thermo Fisher Scientific Inc. Main Business Overview
11.3.5 Thermo Fisher Scientific Inc. Latest Developments
11.4 Silliker Inc.
11.4.1 Silliker Inc. Company Information
11.4.2 Silliker Inc. Infant Formula Testing Product Offered
11.4.3 Silliker Inc. Infant Formula Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Silliker Inc. Main Business Overview
11.4.5 Silliker Inc. Latest Developments
11.5 Accugen Laboratories, Inc.
11.5.1 Accugen Laboratories, Inc. Company Information
11.5.2 Accugen Laboratories, Inc. Infant Formula Testing Product Offered
11.5.3 Accugen Laboratories, Inc. Infant Formula Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Accugen Laboratories, Inc. Main Business Overview
11.5.5 Accugen Laboratories, Inc. Latest Developments
11.6 Intertek Group PLC
11.6.1 Intertek Group PLC Company Information
11.6.2 Intertek Group PLC Infant Formula Testing Product Offered
11.6.3 Intertek Group PLC Infant Formula Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Intertek Group PLC Main Business Overview
11.6.5 Intertek Group PLC Latest Developments
11.7 Eurofins Central Analytical Laboratories
11.7.1 Eurofins Central Analytical Laboratories Company Information
11.7.2 Eurofins Central Analytical Laboratories Infant Formula Testing Product Offered
11.7.3 Eurofins Central Analytical Laboratories Infant Formula Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Eurofins Central Analytical Laboratories Main Business Overview
11.7.5 Eurofins Central Analytical Laboratories Latest Developments
11.8 ELISA Technologies, Inc.
11.8.1 ELISA Technologies, Inc. Company Information
11.8.2 ELISA Technologies, Inc. Infant Formula Testing Product Offered
11.8.3 ELISA Technologies, Inc. Infant Formula Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 ELISA Technologies, Inc. Main Business Overview
11.8.5 ELISA Technologies, Inc. Latest Developments
11.9 Bureau Veritas S.A.
11.9.1 Bureau Veritas S.A. Company Information
11.9.2 Bureau Veritas S.A. Infant Formula Testing Product Offered
11.9.3 Bureau Veritas S.A. Infant Formula Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Bureau Veritas S.A. Main Business Overview
11.9.5 Bureau Veritas S.A. Latest Developments
11.10 SGS SA
11.10.1 SGS SA Company Information
11.10.2 SGS SA Infant Formula Testing Product Offered
11.10.3 SGS SA Infant Formula Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 SGS SA Main Business Overview
11.10.5 SGS SA Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.